Amyloid-β-driven Alzheimer's disease reshapes the colonic immune system in mice

淀粉样蛋白β驱动的阿尔茨海默病会重塑小鼠的结肠免疫系统。

阅读:17
作者:Priya Makhijani ,Taylor R Valentino ,Max Manwaring-Mueller ,Rohini Emani ,Wei-Chieh Mu ,Carlos Galicia Aguirre ,Christopher Ryan Tan ,Anand Rane ,Kenneth A Wilson ,Alexander Kifle ,Nan Chen ,Huixun Du ,Fei Wu ,Jenny Hong Yu Ng ,Benjamin D Ambrose ,Prasanna Vadhana Ashok Kumaar ,Saad Khan ,Shawn Winer ,Chao Wang ,Arthur Mortha ,David Furman ,Birgit Schilling ,Lisa M Ellerby ,Olga L Rojas ,Julie K Andersen ,Daniel A Winer

Abstract

The "gut-brain axis" is an emerging target in Alzheimer's disease (AD), although its immunological features remain poorly understood. Using single-cell RNA sequencing, coupled to extensive spectral-tuning flow cytometry validation of the colon immune compartment in the 5XFAD amyloid-β mouse model, we found several AD-associated changes including in B/plasma cell activity. Notably, levels of CXCR4+ antibody-secreting cells are reduced in 5XFAD colons. This change corresponds with accumulating CXCR4+ B cells and gut-specific IgA+ cells in the brain and dura mater, respectively. Consistently, a chemokine ligand for CXCR4, CXCL12, is expressed at higher levels in the 5XFAD brain and in in silico-analyzed human AD brain studies, supporting altered neuroimmune trafficking. An inulin prebiotic fiber diet could expand gut IgA+ cells, rescue peripheral Treg levels, reduce dysbiosis, improve serum microbial metabolite levels, and attenuate overall AD-associated frailty. Our study reveals key aspects of the gut-brain axis and highlights potential targets against AD.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。